Allergy Therapeutics (LON:AGY) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?

Shares of Allergy Therapeutics plc (LON:AGY) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4.59 ($0.06) and traded as low as GBX 4.50 ($0.06). Allergy Therapeutics shares last traded at GBX 5.42 ($0.07), with a volume of 493,909 shares changing hands.

Allergy Therapeutics Trading Up 0.4 %

The firm has a market capitalization of £263.30 million, a PE ratio of -91.67, a PEG ratio of -30.70 and a beta of 1.40. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22. The stock’s fifty day simple moving average is GBX 4.78 and its 200 day simple moving average is GBX 4.61.

Allergy Therapeutics Company Profile

Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.